Stanford University
Showing 10,691-10,700 of 13,040 Results
-
Hyongsok Tom Soh
W. M. Keck Foundation Professor of Electrical Engineering, Professor of Radiology (Diagnostic Sciences Laboratory) and of Bioengineering
BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.
-
Eric R. Sokol, MD
Professor of Obstetrics and Gynecology (Gynecology and Gynecologic Specialties/Urogynecology) and, by courtesy, of Urology
Current Research and Scholarly InterestsMy research is focused on the development and testing of novel minimally invasive treatment modalities for complex pelvic floor disorders.
-
Elsa Sola
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsCirrhosis is a common condition and is associated with recurrent complications. Therapeutic options are limited and the management of complications has been similar for the past decades. The only definitive treatment is liver transplantation; however, this is limited by the number of organs and the risk of complications on the waiting list. Patients with cirrhosis present with profound immune disturbances, but to date there are no therapeutic strategies to restore immune responses.
Dr Sola’s research interest if focused on understanding the mechanisms of immune dysfunction in cirrhosis to guide the development of future therapeutic options. With her research background in Hepatology and Immunology, Dr Sola is using novel techniques to improve the understanding of cirrhosis progression. She is leveraging her skills in human organoids to develop cirrhosis-derived immune organoids as a platform for investigating mechanisms of immune dysfunction and screening new therapeutic options.
